HealthTree Logo
search more_vert
person Sign In / Create Account

Clinical Expertise

  • Myelofibrosis


I am a translational cancer researcher in the field of myeloid malignancies, with a focus on myeloproliferative neoplasms (MPN). My laboratory studies the biology, genetics, and therapy of myeloid cancers using primary human samples, murine models and multiple in vitro model systems. We use standard biochemical assays, proteomics, multi-parameter flow cytometry, in vivo functional genomics (including CRISPR) and next generation sequencing technologies. Current projects in my laboratory are focused on the biology of mutant calreticulin in MPN, hematopoietic-stromal interactions in the context of myelofibrosis, , the differential molecular dependencies of disease-propagating stem cells in myeloid cancers, identification of heritability alleles for familial MPN. My laboratory is actively expanding currently so please contact me if you are an exceptionally motivated post-doctoral candidate interested in joining my group.


Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

Get the latest thought leadership on Myelofibrosis delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myelofibrosis Newsletter" for Myelofibrosis news, life with Myelofibrosis stories, Myelofibrosis clinical trials, Myelofibrosis 101 articles and events with Myelofibrosis experts.

Thanks to our HealthTree Community for Myelofibrosis Sponsors:

Karyopharm Therapeutics

Follow Us

facebook instagram youtube